Related by context. Frequent words. (Click for all words.) 85 Phase IIa clinical 83 Phase 2b clinical 82 Phase 2a 81 Phase IIb clinical 81 Phase IIa 80 Phase 2a trial 80 Phase 2b study 80 Phase IIa trial 79 Phase III clinical 78 Phase 2b trial 78 Phase Ib 77 pivotal Phase III 77 phase IIb 77 Phase IIb trial 76 Phase 1b 76 Phase IIb 75 Phase 2b 74 Phase III 74 pivotal Phase 74 dose escalation trial 73 multiple ascending dose 71 Phase III pivotal 71 Phase II 71 confirmatory Phase 3 70 PRX # 70 clinical trial 70 dose escalation study 70 randomized Phase 69 Phase III clinical trials 69 NGX# 68 placebo controlled 68 single ascending dose 67 investigational compound 67 CRx 67 randomized placebo controlled 67 investigational drug 66 double blind placebo 66 Phase III trials 65 ISIS # 65 Investigational Device Exemption IDE 65 label dose escalation 65 RDEA# 65 Phase 65 randomized controlled clinical 65 ZYBRESTAT 65 preclinical studies 64 preclinical 64 randomized controlled 64 HGS ETR1 64 investigational oral 63 multicenter 63 LEVADEX 63 safety tolerability 63 RG# [001] 63 tolerability 63 multicenter randomized double 63 initiate Phase 63 denufosol 63 blind randomized placebo 63 CA4P 63 randomized clinical 63 pharmacokinetic 63 eculizumab 63 randomized double 63 INCB# [002] 62 MLN# 62 LymphoStat B 62 AP# [003] 62 AACR NCI EORTC 62 dose escalation 62 Zerenex 62 relapsing remitting multiple sclerosis 62 Atiprimod 62 clinical trials 62 oral formulation 62 ACTEMRA 62 eltrombopag 62 Azixa 61 microplasmin 61 tolerability profile 61 ADX# 61 IMGN# 61 CYT# 61 prospective randomized 61 ANAVEX #-# [003] 61 pharmacodynamics 61 IDX# 61 dimebon 61 talactoferrin 60 laquinimod 60 unblinded 60 XL# [003] 60 MGCD# [001] 60 AEZS 60 cutaneous T cell 60 cetrorelix 60 carfilzomib 60 HspE7 60 castration resistant prostate cancer 60 GRN#L 60 MDV#